Description
Product details
LTROLAMINE 25 is a prescription medicine containing Eltrombopag Olamine Tablets 25 mg, developed to support patients suffering from low platelet count (thrombocytopenia). Platelets play a vital role in blood clotting, and a reduced platelet count can significantly increase the risk of bleeding and related complications. LTROLAMINE 25 works by stimulating platelet production in the bone marrow, thereby helping the body maintain a healthier platelet level and reducing bleeding risks. Eltrombopag Olamine is widely used in hematology and liver-related disorders where platelet deficiency is a major concern. LTROLAMINE 25 is formulated with precision to ensure effectiveness, safety, and consistent therapeutic outcomes when used under medical supervision. What is Eltrombopag Olamine Tablets 25 mg? Eltrombopag Olamine is an oral thrombopoietin receptor agonist. It mimics the action of thrombopoietin, a natural hormone responsible for regulating platelet production. By activating thrombopoietin receptors on bone marrow cells, Eltrombopag increases platelet formation and release into the bloodstream. LTROLAMINE 25 is available in tablet form, making it convenient for long-term management of chronic platelet disorders. Uses of LTROLAMINE 25 LTROLAMINE 25 is primarily prescribed for conditions associated with low platelet counts, including: Chronic Immune Thrombocytopenia (ITP) Used in adults and children who do not respond adequately to corticosteroids, immunoglobulins, or splenectomy. Aplastic Anemia Helps stimulate platelet production in patients with severe aplastic anemia who have not responded to immunosuppressive therapy. Hepatitis C–Related Thrombocytopenia Supports patients with chronic hepatitis C by improving platelet count, enabling them to receive antiviral therapy safely. Bone Marrow Disorders Assists in managing thrombocytopenia caused by bone marrow suppression or dysfunction. How LTROLAMINE 25 Works Eltrombopag Olamine works by binding to thrombopoietin receptors (TPO receptors) found on bone marrow precursor cells. Once activated, these receptors stimulate the growth and differentiation of megakaryocytes, which are responsible for producing platelets. Mechanism of Action Activates thrombopoietin receptors Increases megakaryocyte proliferation Enhances platelet production Improves circulating platelet count Reduces bleeding risk Unlike platelet transfusions, LTROLAMINE 25 supports the body’s natural platelet production process, making it suitable for long-term therapy. Key Benefits of LTROLAMINE 25 Effectively Raises Platelet Count Helps maintain platelet levels within a safer range, reducing the need for frequent transfusions. Oral Administration Tablet form ensures ease of use and better patient compliance. Long-Term Management Suitable for chronic conditions like ITP and aplastic anemia. Reduces Bleeding Risk Lower chances of spontaneous bleeding, bruising, or internal hemorrhage. Improves Quality of Life Patients experience greater confidence in daily activities with reduced bleeding concerns. Clinically Proven Molecule Eltrombopag is supported by extensive clinical research in hematological disorders. Dosage and Administration The dosage of LTROLAMINE 25 is decided by the treating physician based on: Patient’s age and weight Platelet count Underlying medical condition Liver function status General Guidelines Taken once daily on an empty stomach Should be taken at least 2 hours before or 4 hours after dairy products, calcium, iron, or mineral supplements Dose adjustments are done based on platelet response ⚠️ Always follow the doctor’s prescription and do not self-adjust the dose. Possible Side Effects of LTROLAMINE 25 Like all medicines, LTROLAMINE 25 may cause side effects, although not everyone experiences them. Common Side Effects Headache Nausea Fatigue Diarrhea Muscle or joint pain Upper respiratory tract infections Less Common but Serious Side Effects Increased liver enzymes Blood clots (if platelet count rises excessively) Cataract formation (with long-term use) Liver function abnormalities Patients are advised to undergo regular blood tests to monitor platelet levels and liver function while on LTROLAMINE 25. Precautions & Warnings Not recommended without medical supervision Caution in patients with liver disease Regular monitoring of platelet count is essential Should not be used during pregnancy unless clearly advised Avoid sudden discontinuation, as platelet count may drop rapidly Inform your doctor about all other medications you are taking to prevent interactions. Storage Instructions Store below 30°C Keep away from moisture and direct sunlight Keep out of reach of children Conclusion LTROLAMINE 25 (Eltrombopag Olamine Tablets 25 mg) is a reliable and effective treatment option for patients suffering from thrombocytopenia due to various medical conditions. By stimulating natural platelet production, it reduces bleeding risk, improves treatment outcomes, and enhances overall quality of life. Its oral formulation, proven efficacy, and role in long-term platelet management make LTROLAMINE 25 a valuable medicine in modern hematology care.
